Clinical trial
Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in…
NCT00178503 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00178503 |
|---|---|
| Title | Methylphenidate for Attention Deficit Hyperactivity Disorder and Autism in Children |
| Official title | ADHD Symptoms in Autism: Cognition, Behavior, Treatment |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Autism, Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug, Other |
| Interventions | Methylphenidate-extended release, Methylphenidate-immediate release, Placebo |
| Enrollment | 24 |
| Start date | Sep 1, 2005 |
| Primary completion | May 1, 2011 |
| Completion | May 1, 2011 |
| First posted | Sep 15, 2005 |
| Last update posted | May 9, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: